首页> 美国卫生研究院文献>Bulletin of the World Health Organization >Experimental studies of vaccination allergy and immunity in tuberculosis
【2h】

Experimental studies of vaccination allergy and immunity in tuberculosis

机译:结核病疫苗接种过敏和免疫的实验研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Results are given for one of a series of projects designed to investigate the relation between observable post-vaccination responses and acquired resistance to tuberculosis. Controlled variations in the dose of BCG vaccine have previously been shown to cause systematic variations in the degree of skin sensitivity to tuberculin and the size of vaccinal lesions in human beings: the purpose of the present project was to see if similar variations would be produced in guinea-pigs and then, by infecting the animals with virulent tubercle bacilli, to see how survival time correlates with tuberculin allergy and vaccinal lesions.Four doses of freshly prepared BCG vaccine, ranging from 1/100 to 10 times the dose ordinarily used for intradermal vaccination of humans, and one dose of heat-killed BCG 100 times that strength, were used to vaccinate five groups of guinea-pigs, each containing 120 animals. A sixth group of 120 animals was not vaccinated. All animals were tuberculin-tested just before and five weeks after vaccination, challenged with a strong dose of H-37 Rv, and then allowed to die, so that survival time could be used as a measure of resistance.As the dose of living BCG was increased, groups of guinea-pigs showed a progressive increase in the average degree of post-vaccination tuberculin allergy, size of vaccinal lesion, and length of survival after virulent infection. The heat-killed BCG resulted in weak allergy and a short survival time, yet the vaccinal lesions averaged about as large as would be expected from a corresponding dose of living BCG. These results (excluding studies of survival time) correspond closely to those found in human studies.The implications of the results with respect to practical BCG vaccination programmes, while no more than speculative at present, point toward possible advantages in inducing high degrees of tuberculin allergy and toward the dubious significance of the vaccinal lesion as an index of a vaccine's immunizing potency.
机译:给出了一系列项目的结果,这些项目旨在调查可观察到的疫苗接种后反应与结核病获得性耐药之间的关系。先前已证明BCG疫苗剂量的受控变化会导致皮肤对结核菌素的敏感性程度和人类疫苗病变的大小发生系统性变化:本项目的目的是观察是否会产生类似的变化。豚鼠,然后用强力结核杆菌感染动物,以了解存活时间与结核菌素过敏和疫苗损害之间的关系。新鲜制备的四剂BCG疫苗的剂量为皮内注射剂量的1/100至10倍对人进行了预防接种,并使用了一剂强度达到其强度100倍的热杀死的卡介苗,为五组豚鼠接种了疫苗,每组包含120只动物。第六组120只动物没有接种疫苗。所有动物均在接种疫苗前和疫苗接种后五周进行了结核菌素测试,用高剂量的H-37 Rv攻击,然后使其死亡,因此存活时间可用作抗药性的衡量标准。豚鼠的接种量增加后,其接种后结核菌素过敏的平均程度,疫苗病变的大小和强毒感染后的生存时间逐渐增加。加热消灭的卡介苗导致变弱的过敏和较短的生存时间,但疫苗病变的平均面积大约与相应剂量的活卡介苗所期望的一样大。这些结果(不包括存活时间的研究)与人类研究的结果非常接近。关于实际的BCG疫苗接种计划的结果的含义虽然目前还只是推测,但指出了诱导高度结核菌素过敏的可能优势并将疫苗病变作为疫苗免疫效力的指标具有可疑的意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号